jueves, 6 de octubre de 2016

Panel develops plan for preventing youth suicide | National Institutes of Health (NIH)

Panel develops plan for preventing youth suicide | National Institutes of Health (NIH)

National Institutes of Health (NIH) - Turning Discovery into Health

Institute/Center

Contact



Panel develops plan for preventing youth suicide

An independent panel convened by the National Institutes of Health (NIH) has developed a 10-year roadmap for advancing research to prevent youth suicide. The panel listed 29 recommendations that address three critical issues: improving data systems, enhancing data collection and analysis methods, and strengthening the research and practice community.
“The complexity of suicide prevention must be embraced in order to forge new research strategies.”
Dr. Todd Little, Professor of Educational Psychology and Leadership at Texas Tech University, Lubbocks
“The complexity of suicide prevention must be embraced in order to forge new research strategies,” said Dr. Todd Little, workshop and panel chair and professor of educational psychology and leadership at Texas Tech University, Lubbock. “We must coordinate numerous surveillance systems, elevate the rigor and breadth of research methods, and build stronger collaborations among the larger policy, practice, and research communities.”
To help close research gaps related to youth suicide and to assess the scientific evidence, NIH convened the Pathways to Prevention Workshop on March 29–30, 2016. The panel of independent experts attended the workshop and developed a report. The report includes recommendations to address these four critical issues over the next decade:
  • The need for surveillance by linking data from multiple sources (e.g., state all-payer databases, emergency room data, electronic health records data).
  • The need to improve measurement across diverse populations and time scales of personal characteristics such as sexual orientation and identity, and environmental contexts that have been associated with suicide risk.
  • The need to help practitioners in identifying effective suicide prevention programs.
  • The need for coordinated education and training opportunities for health care providers, schools, agencies, families, and communities to remove the stigma associated with suicide.
The panel cited several barriers that impede efforts to combat youth suicide. For example, there is limited availability of linked data systems to facilitate identifying important risk factors for youth suicide. Researchers have not assessed measures of suicide risk and protective factors at multiple levels (including the individual, family, peer group, school, and community) over time. Additionally, the stigma associated with suicide has resulted in the misclassification and underreporting of suicide and suicide attempts and has reduced opportunities for successful intervention.
More than 42,000 Americans die from suicide each year. It’s the 10th leading cause of death in the United States and the second leading cause of death in youth (10 to 24 years of age) and young adults (25 to 34 years of age), claiming the lives of 12,073 individuals in these age brackets in 2014, according to the Centers for Disease Control and Prevention. Risk factors such as depression, other mental disorders, and substance use, along with precipitating events such as relationship loss or disruption; and environmental circumstances like barriers to accessing mental health treatment, can contribute to suicidal behavior.
“Although youth suicide is pervasive, it can be prevented,” said Dr. Little. “Researchers, practitioners, and policymakers must unite to stop suicide and circumvent the devastating pain and suffering it causes. The recommendations in this roadmap can help reduce youth suicide and guide us toward our ultimate goal of eliminating it.”
The panel’s final report, which identifies future research and clinical priorities, incorporates its assessment of the workshop’s systematic review of the scientific evidence, expert presentations, audience input, and public comments. This independent report is not a policy statement of the NIH or the federal government.
The workshop was co-sponsored by the NIH Office of Disease Prevention (ODP), the National Institute of Mental Health (NIMH), the National Institute on Drug Abuse (NIDA), and the National Center for Complementary and Integrated Health. The evidence report was prepared by the Johns Hopkins Evidence-Based Practice Center under contract to the Agency for Healthcare Research and Quality.
The five-member panel included experts in the fields of clinical psychology, statistics, health education, prevention and community health research, methods research, and epidemiology. Panel member biographies, an archived NIH VideoCast (link to the P2P YSP workshop resources page where the VideoCast is listed) of the workshop, and additional resources are available athttps://prevention.nih.gov/programs-events/pathways-to-prevention/workshops/binders/2016/suicide-prevention/panel-members.
Interviews with panel members can be arranged by contacting Deborah Langer at 301-827-5575 or langerdh@od.nih.gov(link sends e-mail).
The ODP assesses, facilitates, and stimulates research in health promotion and disease prevention in collaboration with the NIH and other public and private partners, and disseminates the results of this research to improve public health. For more information about the ODP, visit http://prevention.nih.gov.
The mission of NIMH is to transform the understanding and treatment of mental illnesses through basic and clinical research, paving the way for prevention, recovery, and cure.
NIDA’s mission is to advance science on the causes and consequences of drug use and addiction and to apply that knowledge to improve individual and public health.
The mission of the NCCIH is to define, through rigorous scientific investigation, the usefulness and safety of complementary and integrative health interventions and their roles in improving health and health care.
About the National Institutes of Health (NIH): NIH, the nation's medical research agency, includes 27 Institutes and Centers and is a component of the U.S. Department of Health and Human Services. NIH is the primary federal agency conducting and supporting basic, clinical, and translational medical research, and is investigating the causes, treatments, and cures for both common and rare diseases. For more information about NIH and its programs, visit www.nih.gov.
NIH…Turning Discovery Into Health®

No hay comentarios:

Publicar un comentario